SURG: Summary for Synergetics USA, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 4:53am EST - Canadian Markets open in 4 hours and 37 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Synergetics USA, Inc. (SURG)

On Nov 23: 1.42 USD 0.00 (0.00%)

MORE ON SURG

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Synergetics USA, Inc. (NCM:SURG) Delayed quote data

Last Trade:	1.42 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	1.42
Open:	N/A
Bid:	1.26 x 1600
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.74 - 1.83
Volume:	0
Avg Vol (3m):	40,938.5
Market Cap:	34.72M
P/E (ttm):	40.57
EPS (ttm):	0.04
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add SURG to Portfolio

Download Data

HEADLINES

•	Stryker set to acquire OtisMed
	AP (Tue, Nov 10)

•	Stryker Announces Agreements To Acquire Assets
	PRNewswire (Tue, Nov 10)

•	SYNERGETICS USA INC Financials
	EDGAR Online Financials (Tue, Nov 3)

•	SYNERGETICS USA INC Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Thu, Oct 29)

•	SYNERGETICS USA INC Files SEC form 10-K, Annual Report
	EDGAR Online (Wed, Oct 28)

•	Q4 2009 Synergetics USA, Inc. Earnings Release - After Market Close
	CCBN (Wed, Oct 28)

•	SYNERGETICS USA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Tue, Oct 20)

•	SYNERGETICS USA INC Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Tue, Jun 16)

•	SYNERGETICS USA INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Jun 15)

•	SYNERGETICS USA INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Mon, Mar 23)

More Headlines for SURG...

ANALYST

EPS Est (next year) (Dec-69) :	N/A
EPS Est (in 2 years) (Dec-69) :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Synergetics USA, Inc. engages in the design, manufacture, and marketing of precision-engineered, microsurgical instruments, and capital equipment and devices primarily for use in vitreoretinal surgery and neurosurgical applications worldwide.

Full Company Profile

Add to Portfolio

Email to a Friend

•